About Us

Why We Exist

OraLiva is a diagnostics company on a mission to catch cancer early—when it’s most treatable. We’re pioneering a new era of non-invasive, AI-powered cytology, ultimately designed for use directly at the point of care. We starting with one of the most overlooked and deadly cancers: oral cancer.

​

Our Solution

OraLiva’s proprietary technology platform combines state-of-the-art biosensing with AI to analyze single-cell data from a simple brush sample. Within minutes, our test detects key cytologic signatures of dysplasia—the cellular warning signs that precede cancer—providing dental providers with lab-grade insight in real time.

Developed in partnership with leaders in cancer cytopathology our system digitizes biology using sensors that learn. It’s a breakthrough in precision medicine: programmable, scalable, and clinically validated.​

​

Our Vision

We’re starting in dentistry, but OraLiva’s impact will reach far beyond the mouth. Our platform is designed to transform how clinicians detect and monitor cancer across multiple organ systems—from oral to cervical to lung—bringing the power of cytopathology and machine learning to frontline care.

At OraLiva, we’re not just detecting disease. We’re shifting the timeline—so patients can act sooner, providers can do more, and lives can be saved.